Sleep Aids (Pharmacies) - Algeria

  • Algeria
  • Revenue in the Sleep Aids market is projected to reach US$1.74m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -1.91%, resulting in a market volume of US$1.58m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.04 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Algeria is experiencing significant growth and development.

Customer preferences:
Customers in Algeria are increasingly seeking sleep aids to address their sleep-related issues. The modern lifestyle, with its fast pace and high stress levels, has led to an increase in sleep disorders among the population. As a result, there is a growing demand for sleep aids that can help individuals achieve better quality sleep and improve their overall well-being.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Algeria is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of pharmaceutical sleep aids and are seeking safer alternatives. Natural sleep aids, such as herbal teas and supplements, are gaining traction as they are perceived to be gentler on the body and have fewer potential side effects. Another trend in the market is the increasing availability and accessibility of sleep aids in pharmacies. Pharmacies in Algeria are expanding their product offerings to cater to the growing demand for sleep aids. This includes stocking a wider range of sleep aid products, both pharmaceutical and natural, to meet the diverse needs and preferences of customers.

Local special circumstances:
Algeria has a relatively young population, with a significant proportion of the population falling within the working age group. This demographic trend has contributed to the high levels of stress and sleep disorders observed in the country. Additionally, the prevalence of chronic diseases, such as diabetes and hypertension, further exacerbates sleep-related issues among the population. These local special circumstances have created a conducive environment for the growth of the Sleep Aids (Pharmacies) market in Algeria.

Underlying macroeconomic factors:
The growing Sleep Aids (Pharmacies) market in Algeria can also be attributed to various underlying macroeconomic factors. Algeria has been experiencing steady economic growth over the years, which has led to an increase in disposable income among the population. As a result, individuals are more willing and able to spend on sleep aids to improve their sleep quality. Furthermore, the government's focus on healthcare and well-being has also played a role in driving the demand for sleep aids, as individuals are becoming more aware of the importance of sleep in maintaining good health. In conclusion, the Sleep Aids (Pharmacies) market in Algeria is developing due to customer preferences for sleep aids, the availability of a wider range of products in pharmacies, local special circumstances such as high stress levels and prevalence of chronic diseases, and underlying macroeconomic factors such as economic growth and government focus on healthcare.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)